Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chiral Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN110914417B reveals high-activity transaminase for chiral amine synthesis, offering cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN103694157A reveals a mild, high-yield route for chiral alpha-chloroaziridines. Discover cost-effective manufacturing solutions for complex nitrogen heterocycles.
Novel two-step synthesis of axially chiral bissulfoxide ligands via oxidative coupling. High enantioselectivity for Rh-catalyzed additions. Reliable supply chain partner.
Patent CN112300047A reveals a novel Ru-catalyzed tandem reductive amination for chiral lactams, offering high enantioselectivity and streamlined manufacturing for pharmaceutical intermediates.
Patent CN101318146A reveals a novel organocatalyst enabling dual-handed synthesis of gamma-nitro ketones with high enantioselectivity, offering cost-effective solutions for API manufacturing.
Novel ferrocene-derived iridium catalyst enables high-efficiency chiral amine synthesis with reduced processing costs for reliable agrochemical intermediate supply chains.
Novel synthesis route for Tacalcitol side chain intermediates reduces cost and improves yield. Reliable supplier for high-purity pharmaceutical intermediates.
Novel bromocyclization method for statin intermediates offers mild conditions and cost reduction for pharmaceutical manufacturing supply chains globally ensuring high purity standards.
Novel patent CN108659031A offers mild conditions for eribulin intermediate. Enhances supply chain reliability and reduces manufacturing costs for pharma partners.
Patent CN1376659A reveals a safe metal borohydride reduction system for high-purity chiral intermediates, offering significant cost and supply chain advantages.
Patent CN103467228A details a mild Pd-catalyzed allyl-aryl coupling for high-purity chiral intermediates, offering significant cost reduction in API manufacturing and robust supply chain reliability.
Patent CN114349585A details a copper-catalyzed asymmetric synthesis of chiral alpha-deuterated pyrrolidines using D2O, offering cost reduction in pharmaceutical intermediate manufacturing.
Patent CN112624901B details a novel refining method for chiral alcohols using polymer-supported catalysts and specific ether solvents, ensuring >99% purity for API manufacturing.
Patent CN1328230C details asymmetric transfer hydrogenation of imines using Rh/Ru/Ir catalysts for high-purity pharmaceutical intermediates.
Patent CN101372484A reveals manganese catalyzed oxidation for high purity PPI intermediates offering supply chain stability and significant cost reduction potential for global pharmaceutical manufacturing partners.
Patent CN104693092A reveals a one-step synthesis for PTP1B inhibitors. Discover cost reduction and supply chain advantages for high-purity pharmaceutical intermediates.
Patent CN110746428A details a novel asymmetric oxidation route for high-purity R-type chiral sulfoxide, offering significant cost reduction in API manufacturing and improved supply chain reliability.
Novel asymmetric catalytic synthesis for chiral fluorinated building blocks. Enhances drug development efficiency and supply chain reliability for pharmaceutical intermediates.
Industrial process for chiral 2-chloro-1-(2,4-dichlorophenyl) ethyl alcohol. High purity, scalable, cost-effective supply for antifungal API manufacturing.
Patent CN100343240C reveals an inorganic base-catalyzed method for high-purity CCR5 antagonist intermediates, offering significant cost reduction and supply chain reliability.